G01N 2333/185
Flaviviruses or group b arboviruses
Official title: Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
G01N2333/185 (Flaviviruses or group b arboviruses) appears on 122 US grants and 217 published applications in this corpus.
Search patents in G01N- Granted patents
- 122
- Published applications
- 217
- Assignees
- 127
- Inventors
- 511
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 3 | 2 |
| 2012 | 0 | 5 |
| 2013 | 3 | 6 |
| 2014 | 3 | 4 |
| 2015 | 5 | 13 |
| 2016 | 4 | 8 |
| 2017 | 10 | 19 |
| 2018 | 15 | 24 |
| 2019 | 13 | 21 |
| 2020 | 9 | 24 |
| 2021 | 12 | 25 |
| 2022 | 10 | 19 |
| 2023 | 12 | 9 |
| 2024 | 11 | 13 |
| 2025 | 4 | 11 |
| 2026 | 8 | 8 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for detecting virus using SSDNA functionalized sensor15 Sep 2026US 12,736,531 B2University of Central Florida Research Foundation, Inc.
- Zika/dengue vaccine and application thereof2 Jun 2026US 12,642,846 B2Institute of Microbiology, Chinese Academy of Sciences
- Methods for reducing electrode gap distances in electronic devices and resulting devices having nanometer electrode gaps via liquid phase molecular layer deposition technique2 Jun 2026US 12,644,858 B2University of Utah Research Foundation
- Antibodies which specifically bind to dengue virus serotype 4 (DENV4) non-structural protein 1 (NS1) and methods of use thereof to detect a DENV4 infection21 Apr 2026US 12,606,611 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods and compositions for the detection of host protein cleavage by group IV viral proteases21 Apr 2026US 12,607,633 B2The Government of the United States of America, as represented by the Secretary of the Navy
- Human antibodies targeting zika virus ns1, ns1 polypeptides and uses thereof10 Sep 2026US 2026/0266820 A1Icahn School of Medicine at Mount Sinai
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
- Micro-balance biosensors to detect whole viruses6 Aug 2026US 2026/0227361 A1University of Utah Research Foundation
- Methods, systems, and arrays for tickborne pathogen and disease analysis9 Jul 2026US 2026/0194522 A1Vibrant Holdings, LLC
- A method for determining the infectivity of a virus18 Jun 2026US 2026/0167703 A1Takeda Vaccines, Inc.
Most cited
By later US patents
- Arbovirus indicative birth defect risk test43US 9,857,372 B1Reliant Immune Diagnostics, Inc. · 2018
- System and method for immediate health assessment response system23US 10,473,659 B2Reliant Immune Diagnostics, Inc. · 2019
- Anti-dengue virus antibodies15US 8,637,035 B2Academia Sinica · 2014
- Antibody molecules to dengue virus and uses thereof13US 9,212,217 B2Visterra, Inc. · 2015
- Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use12US 9,000,141 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · 2015